FDA-cleared profile

BoneView

Gleamer · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.

Clinical role
Concurrent detection and localization aid during radiograph interpretation; the clinical user makes the primary diagnosis and patient-management decision.
Images and patients
X-ray/Radiography · Spine
Key limitation
Keep in mind: Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Spine Input: DICOM 2D radiographs in specified views for ankle, foot, knee, tibia/fibula, wrist, hand, elbow, forearm, humerus, shoulder, clavicle, pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine, subject to age-specific labeling.
  • Who uses it?Intended users: Clinicians authorized to diagnose fractures in primary care, emergency medicine, urgent care, specialty care such as orthopedics, and radiologists reviewing radiographs.
  • What does the software produce?Output: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
  • What is its most important limitation?Key limitation: Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.

Clinical takeaway. Clinical role: BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.

Evidence takeaway. Evidence from the reviewed source record: The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
BoneView 1.1-US analyzes eligible 2D radiographs as a concurrent fracture-reading aid. Limb examinations apply to patients aged 2 years and older; pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are limited to adults older than 21 years. Clinical users retain diagnostic and patient-management responsibility.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Concurrent detection and localization aid during radiograph interpretation; the clinical user makes the primary diagnosis and patient-management decision.
  • Exact FDA submission
  • Checked 2026-09-08
Required input
DICOM 2D radiographs in specified views for ankle, foot, knee, tibia/fibula, wrist, hand, elbow, forearm, humerus, shoulder, clavicle, pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine, subject to age-specific labeling.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Primary care, emergency medicine, urgent care, specialty care, and radiology workflows for eligible adult and pediatric radiographs.
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Clinicians authorized to diagnose fractures in primary care, emergency medicine, urgent care, specialty care such as orthopedics, and radiologists reviewing radiographs.
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Not indicated below age 2. Pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine are adult-only. Use is limited to the specified body parts and views; out-of-scope images can return NOT AVAILABLE. Results are concurrent decision support and do not replace clinical interpretation.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact submission adds pediatric indications using a 2,000-radiograph standalone study and references the unchanged algorithm's earlier 24-reader, 480-case adult MRMC study. Pediatric operating points and adult aided-reader endpoints are kept distinct.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Pediatric standalone: 90.9% at the high-sensitivity operating point and 79.2% at the high-specificity operating point; adult carried-forward MRMC aided sensitivity: 75.2%.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported specificity
Pediatric standalone: 82.1% at the high-sensitivity operating point and 96.5% at the high-specificity operating point; adult carried-forward MRMC aided specificity: 95.6%.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

Pediatric high-sensitivity operating-point sensitivity

90.9 percent

  • EndpointExamination-level fracture sensitivity at DOUBT FRACT operating point
  • Population2,000 radiographs from patients aged 2-21 years; 1,000 positive and 1,000 negative examinations
  • Tested versionBoneView 1.1-US configuration described in K222176

Pediatric high-sensitivity operating-point specificity

82.1 percent

  • EndpointExamination-level fracture specificity at DOUBT FRACT operating point
  • Population2,000 radiographs from patients aged 2-21 years; 1,000 positive and 1,000 negative examinations
  • Tested versionBoneView 1.1-US configuration described in K222176

Pediatric high-specificity operating-point specificity

96.5 percent

  • EndpointExamination-level fracture specificity at FRACT operating point
  • Population2,000 radiographs from patients aged 2-21 years; 1,000 positive and 1,000 negative examinations
  • Tested versionBoneView 1.1-US configuration described in K222176

Pediatric high-specificity operating-point sensitivity

79.2 percent

  • EndpointExamination-level fracture sensitivity at FRACT operating point
  • Population2,000 radiographs from patients aged 2-21 years; 1,000 positive and 1,000 negative examinations
  • Tested versionBoneView 1.1-US configuration described in K222176

Adult carried-forward aided-reader sensitivity

75.2 percent

  • EndpointReader fracture-detection sensitivity with BoneView assistance
  • Population480 adult cases interpreted by 24 readers in the predicate MRMC study
  • Tested versionUnchanged BoneView algorithm carried forward in K222176 from K212365

Adult carried-forward aided-reader specificity

95.6 percent

  • EndpointReader fracture-detection specificity with BoneView assistance
  • Population480 adult cases interpreted by 24 readers in the predicate MRMC study
  • Tested versionUnchanged BoneView algorithm carried forward in K222176 from K212365

K222176 BoneView pediatric standalone validation

  • DesignStandalone fracture-detection performance comparison between pediatric and adult datasets at prespecified high-sensitivity and high-specificity operating points.
  • Population2,000 radiographs from patients aged 2-21 years, balanced between fracture-positive and fracture-negative examinations and spanning the pediatric-labeled anatomy and eight manufacturers.
  • Scopeexact submission
  • Tested versionBoneView 1.1-US configuration described in K222176
  • Samplen=2000
  • IndependenceSponsor or vendor study

K222176

The packet states the pediatric dataset was separate from training, tuning, and operating-point data. Dataset separation does not establish independent investigators.

BoneView adult MRMC study carried forward in K222176

  • DesignFully crossed retrospective multiple-reader, multiple-case study with aided and unaided sessions separated by at least one month.
  • Population480 adult cases interpreted by 24 clinical readers, with a three-US-board-certified-radiologist reference standard and multiple manufacturers.
  • Scopeexact submission
  • Tested versionUnchanged BoneView algorithm carried forward in K222176 from K212365
  • Samplen=480
  • IndependenceSponsor or vendor study

K222176 · K212365

The K222176 summary says no new clinical study was conducted and carries this predicate study forward because the algorithm was unchanged.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-submission FDA recall query returned no native recall record for K222176. This limited query does not establish absence of recalls or other safety information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

No product-specific code

NICE HTG739 conditionally recommends BoneView for NHS use during a two-year evidence-generation period, subject to evidence-generation agreements and appropriate regulatory and DTAC approval; this is not a reimbursement determination.

NICE guidance for the NHS in England · England · Effective 2025-01-14

NICE's exploratory model uses GBP 1 per scan and states actual software, implementation, and postmarket costs are uncertain. Treat that figure as a health-technology-model assumption, not a vendor quote.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM 2D radiographs in specified views for ankle, foot, knee, tibia/fibula, wrist, hand, elbow, forearm, humerus, shoulder, clavicle, pelvis, hip, femur, ribs, thoracic spine, and lumbosacral spine, subject to age-specific labeling.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA 510(k) K222176: BoneView 1.1-US

  2. Routing

    Source context, not route validation: BoneView receives studies from a DICOM source through an intermediate DICOM node and returns result files to a DICOM destination such as PACS or radiological equipment for viewing or onward transfer. Source and destination can differ.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA 510(k) K222176: BoneView 1.1-US

  3. AI processing

    Source context, not route validation: On-premise or cloud deployment connected to computing platforms, X-ray systems, or PACS, as described in the exact FDA comparison table.

    Scope: Exact FDA submission. Current hosting region, retention, availability, and contracted topology still require site-specific confirmation.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-08 · FDA 510(k) K222176: BoneView 1.1-US

  4. Returned objects

    Source context, not route validation: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA 510(k) K222176: BoneView 1.1-US

  5. Viewer/worklist/report

    Unresolved route: A configurable summary image and processed result images with solid or dotted fracture bounding boxes, processing frames, finding counts, and out-of-indication cautions; results can be toggled while original images remain unchanged.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA 510(k) K222176: BoneView 1.1-US

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premise or cloud deployment connected to computing platforms, X-ray systems, or PACS, as described in the exact FDA comparison table.
  • Exact FDA submission
  • Checked 2026-09-08

Current hosting region, retention, availability, and contracted topology still require site-specific confirmation.

Integration
BoneView receives studies from a DICOM source through an intermediate DICOM node and returns result files to a DICOM destination such as PACS or radiological equipment for viewing or onward transfer. Source and destination can differ.
  • Exact FDA submission
  • Checked 2026-09-08
Security
The exact FDA comparison table labels the device HIPAA compliant; it does not disclose the control scope, audit period, encryption, access-control, vulnerability-management, or incident-response evidence needed for procurement review.
  • Exact FDA submission
  • Checked 2026-09-08
Monitoring
Monitor age and body-part eligibility, supported-view routing, NOT AVAILABLE results, bounding-box operating point, DICOM delivery, disagreements and overrides, false negatives and false positives, downstream imaging/referrals, downtime, updates, complaints, and exact-submission recalls.
  • Exact FDA submission
  • Checked 2026-09-08

Buyer acceptance guidance derived from FDA labeling and NICE evidence gaps; it is not a claimed vendor monitoring service.

Exact DICOM source-to-destination workflow

The exact packet describes automatic receipt through an intermediate DICOM node and return of summary/result images to a potentially different DICOM destination for PACS or equipment viewing.

exact submission · checked 2026-09-08

Current BoneView family workflow

Gleamer's current US BoneView page describes automatic second reading of trauma X-rays integrated into the reading workflow for adults and children over age 2. Current family claims are not used to broaden the exact K222176 body-part, view, or age labeling.

product family · checked 2026-09-08

NICE evidence-generation controls

NICE HTG739 calls for clear local disagreement protocols and evidence collection on diagnostic accuracy, costs, referrals, treatment changes, software failures, subgroup performance, implementation costs, and postmarket surveillance during conditional NHS use.

product family · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K222176
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Spine
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08

The controlled directory anatomy is Spine; exact labeling also covers specified limbs, pelvis, hip, femur, ribs, and clavicle.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-03-02
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-08Last searched
26Fields reviewed
12Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads

Stored PubMed and trial candidates were screened by identifier and metadata only. None was promoted without full-text or registry-record review; this is not a systematic evidence review. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, health technology guidance, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-08 - Exact FDA submission

    NICE's GBP 1-per-scan figure is an exploratory model assumption, not a BoneView quote or public list price.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    NICE HTG739 is conditional English NHS adoption guidance, not a payer coverage or product-specific reimbursement determination.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Exact-version onboarding, role-based training, competency checks, support response, and retraining after updates were not established.

10 sources - 3 history items

Source ledger

  1. K222176 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BoneView model card (K222176)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: purpose, modality, intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. FDA 510(k) K222176: BoneView 1.1-US

    U.S. Food and Drug Administration - Published 2023-03-02 - Accessed 2026-09-07

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, security

  8. BoneView AI fracture detection

    Gleamer - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow, implementationCapabilities

  9. NICE HTG739: AI technologies to help detect fractures on X-rays in urgent care

    National Institute for Health and Care Excellence - Published 2025-01-14 - Accessed 2026-09-08

    Scope: conditionalAdoption, economics, evidenceGaps, implementationCapabilities

  10. openFDA exact recall query for K222176

    U.S. Food and Drug Administration - Accessed 2026-09-07

    Scope: postmarketSafety

Research history

  1. K222176 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251078

AutoDensity

Eos Imaging

AutoDensity estimates L1-L4 spine bone-mineral density from EOSedge dual-energy AP radiographs for opportunistic orthopedic pre-surgical assessment; it is not a replacement for DXA confirmation.

Modality
X-ray/Radiography
Anatomy
Spine
Decision
2025-11-14
FDA-cleared K241593

BoneMetrics (US)

Gleamer SAS

Authorized purpose: BoneMetrics is fully automated software that assists trained radiology professionals with Cobb-angle measurement on frontal spine radiographs in patients aged four years or older with suspected or present spinal deformity or scoliosis; it is not a replacement for complete evaluation or sole diagnosis.

Modality
X-ray/Radiography
Anatomy
Spine
Decision
2025-02-05
FDA-cleared K221632

Spine CAMP™

Medical Metrics, Inc.

Authorized purpose: Automated analysis of sagittal lumbar and cervical spine radiographs to produce static and motion metrics supporting qualified practitioners' decision-making in skeletally mature patients age 18 and above.

Modality
X-ray/Radiography
Anatomy
Spine
Decision
2022-10-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history